Literature DB >> 22364820

Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis.

Deanna M Green1, J Michael Collaco, Kathryn E McDougal, Kathleen M Naughton, Scott M Blackman, Garry R Cutting.   

Abstract

OBJECTIVE: To quantify the relative contribution of factors other than cystic fibrosis transmembrane conductance regulator genotype and environment on the acquisition of Pseudomonas aeruginosa (Pa) by patients with cystic fibrosis. STUDY
DESIGN: Lung infection with Pa and mucoid Pa was assessed using a co-twin study design of 44 monozygous (MZ) and 17 dizygous (DZ) twin pairs. Two definitions were used to establish infection: first positive culture and persistent positive culture. Genetic contribution to infection (ie, heritability) was estimated based on concordance analysis, logistic regression, and age at onset of infection through comparison of intraclass correlation coefficients.
RESULTS: Concordance for persistent Pa infection was higher in MZ (0.83; 25 of 30 pairs) than DZ twins (0.45; 5 of 11 pairs), generating a heritability of 0.76. Logistic regression adjusted for age corroborated genetic control of persistent Pa infection. The correlation for age at persistent Pa infection was higher in MZ twins (0.589; 95% CI, 0.222-0.704) than in DZ twins (0.162; 95% CI, -0.352 to 0.607), generating a heritability of 0.85.
CONCLUSION: Genetic modifiers play a significant role in the establishment and timing of persistent Pa infection in individuals with cystic fibrosis.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22364820      PMCID: PMC3682831          DOI: 10.1016/j.jpeds.2012.01.042

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  28 in total

1.  Early diagnosis of cystic fibrosis in the newborn period and risk of Pseudomonas aeruginosa acquisition in the first 10 years of life: A registry-based longitudinal study.

Authors:  S S Wang; S C FitzSimmons; L A O'Leary; M J Rock; M L Gwinn; M J Khoury
Journal:  Pediatrics       Date:  2001-02       Impact factor: 7.124

2.  Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening.

Authors:  Judith H Maselli; Marci K Sontag; Jill M Norris; Todd MacKenzie; Jeff S Wagener; Frank J Accurso
Journal:  Pediatr Pulmonol       Date:  2003-04

3.  Association between genetically determined pancreatic status and lung disease in adult cystic fibrosis patients.

Authors:  Yann Loubières; Dominique Grenet; Brigitte Simon-Bouy; Jacques Medioni; Paul Landais; Claude Férec; Marc Stern
Journal:  Chest       Date:  2002-01       Impact factor: 9.410

4.  Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease.

Authors:  Jessica E Pittman; Elizabeth H Calloway; Michelle Kiser; John Yeatts; Stephanie D Davis; Mitchell L Drumm; Michael S Schechter; Margaret W Leigh; Mary Emond; Annelies Van Rie; Michael R Knowles
Journal:  Pediatr Pulmonol       Date:  2010-12-30

5.  Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition.

Authors:  M R Kosorok; L Zeng; S E West; M J Rock; M L Splaingard; A Laxova; C G Green; J Collins; P M Farrell
Journal:  Pediatr Pulmonol       Date:  2001-10

6.  Analysis of the two common alpha-1-antitrypsin deficiency alleles PiMS and PiMZ as modifiers of Pseudomonas aeruginosa susceptibility in cystic fibrosis.

Authors:  P Meyer; A Braun; A A Roscher
Journal:  Clin Genet       Date:  2002-10       Impact factor: 4.438

7.  TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis.

Authors:  P D Arkwright; S Laurie; M Super; V Pravica; M J Schwarz; A K Webb; I V Hutchinson
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

8.  Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study.

Authors:  Edward F McKone; Scott S Emerson; Karen L Edwards; Moira L Aitken
Journal:  Lancet       Date:  2003-05-17       Impact factor: 79.321

9.  Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

Authors:  Julia Emerson; Margaret Rosenfeld; Sharon McNamara; Bonnie Ramsey; Ronald L Gibson
Journal:  Pediatr Pulmonol       Date:  2002-08

Review 10.  Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management.

Authors:  Margaret Rosenfeld; Bonnie W Ramsey; Ronald L Gibson
Journal:  Curr Opin Pulm Med       Date:  2003-11       Impact factor: 3.155

View more
  11 in total

1.  Gene expression in transformed lymphocytes reveals variation in endomembrane and HLA pathways modifying cystic fibrosis pulmonary phenotypes.

Authors:  Wanda K O'Neal; Paul Gallins; Rhonda G Pace; Hong Dang; Whitney E Wolf; Lisa C Jones; XueLiang Guo; Yi-Hui Zhou; Vered Madar; Jinyan Huang; Liming Liang; Miriam F Moffatt; Garry R Cutting; Mitchell L Drumm; Johanna M Rommens; Lisa J Strug; Wei Sun; Jaclyn R Stonebraker; Fred A Wright; Michael R Knowles
Journal:  Am J Hum Genet       Date:  2015-01-29       Impact factor: 11.025

2.  The influence of genetics on cystic fibrosis phenotypes.

Authors:  Michael R Knowles; Mitchell Drumm
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

Review 3.  Cystic fibrosis genetics: from molecular understanding to clinical application.

Authors:  Garry R Cutting
Journal:  Nat Rev Genet       Date:  2014-11-18       Impact factor: 53.242

Review 4.  Cystic fibrosis: a clinical view.

Authors:  Carlo Castellani; Baroukh M Assael
Journal:  Cell Mol Life Sci       Date:  2016-10-05       Impact factor: 9.261

Review 5.  Cystic fibrosis.

Authors:  Felix Ratjen; Scott C Bell; Steven M Rowe; Christopher H Goss; Alexandra L Quittner; Andrew Bush
Journal:  Nat Rev Dis Primers       Date:  2015-05-14       Impact factor: 52.329

6.  Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.

Authors:  Mary J Emond; Tin Louie; Julia Emerson; Jessica X Chong; Rasika A Mathias; Michael R Knowles; Mark J Rieder; Holly K Tabor; Debbie A Nickerson; Kathleen C Barnes; Lung Go; Ronald L Gibson; Michael J Bamshad
Journal:  PLoS Genet       Date:  2015-06-05       Impact factor: 5.917

7.  Host genetic diversity influences the severity of Pseudomonas aeruginosa pneumonia in the Collaborative Cross mice.

Authors:  Nicola Ivan Lorè; Fuad A Iraqi; Alessandra Bragonzi
Journal:  BMC Genet       Date:  2015-08-28       Impact factor: 2.797

8.  Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis.

Authors:  Kevin J Psoter; Anneclaire J De Roos; Jon Wakefield; Jonathan D Mayer; Margaret Rosenfeld
Journal:  BMC Pulm Med       Date:  2017-07-27       Impact factor: 3.317

9.  The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention.

Authors:  Thomas H Hampton; Deanna M Green; Garry R Cutting; Hilary G Morrison; Mitchell L Sogin; Alex H Gifford; Bruce A Stanton; George A O'Toole
Journal:  Microbiome       Date:  2014-04-28       Impact factor: 14.650

10.  The Effect of Strict Segregation on Pseudomonas aeruginosa in Cystic Fibrosis Patients.

Authors:  Rosa van Mansfeld; Angelica de Vrankrijker; Roland Brimicombe; Harry Heijerman; Ferdinand Teding van Berkhout; Cristian Spitoni; Sanne Grave; Cornelis van der Ent; Tom Wolfs; Rob Willems; Marc Bonten
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.